IGF1R and hepatocellular carcinoma: In human HCC patients, IGF1R expression was negatively correlated with patient survival (Hazard ratio = 1.56, p = 0.013), wherein patients with high IGF1R levels survived significantly less than patients with low-IGF1R levels (38 vs. 71 months) (Figure 5H).